Funding support lacking in search for HIV vaccine
- PMID: 11366091
Funding support lacking in search for HIV vaccine
Abstract
AIDS: AIDSVAX is the only vaccine in phase III efficacy trials, but most experts do not believe that this vaccine is the final word in HIV prevention. Another phase III trial could be at least 3 years away, because no other vaccines are near that stage of development. HIV-1 Delta 4 is a vaccine in development that uses a mutated form of the virus; however, there are public health concerns about introducing a new form of the virus into the population. Canary pox-vector vaccine is discussed and five versions of the vaccine are in early clinical trials. Two DNA vaccines are also being investigated.
Similar articles
-
Controversial HIV vaccine enters phase III trials amid skepticism.AIDS Alert. 1998 Dec;13(12):133-4, 136. AIDS Alert. 1998. PMID: 11366059
-
Large HIV vaccine trial begins.GMHC Treat Issues. 1998 Oct;12(10):1-5. GMHC Treat Issues. 1998. PMID: 11365900
-
Vaccine to prevent AIDS overstated.Res Initiat Treat Action. 1999 Jan;5(1):11-2. Res Initiat Treat Action. 1999. PMID: 11366223
-
[The quest for an HIV vaccine].Bull Acad Natl Med. 2005 May;189(5):831-44; discussion 844. Bull Acad Natl Med. 2005. PMID: 16433455 Review. French.
-
AIDSVAX. VaxGen.Curr Opin Investig Drugs. 2001 Sep;2(9):1203-8. Curr Opin Investig Drugs. 2001. PMID: 11717805 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical